OncoInsight
Insightful Breakthrough Medicine  for Immune Cell Therapy

Allogeneic Natural Killer Cells Engineered to Solid tumor

Natural killer cells can be xenografted and have the potential to become off-the-shelf products, making CAR-NK cell therapies universal products. These products are safer than CAR-T cell therapy.

iPSC derived Mesenchymal stem cells with Immunomodulatory ability

iPSC-derived MSCs express typical MSC immunophenotype, and seek to develop products as potential sources of unlimited, standardized, high‐quality cells for therapeutic applications in immune disease.

Humanized Mice as Unique Tools for Human-Specific Studies

Humanized mice support the development of multiple cellular components of the human immune system, many of which are functional and used in modeling key portions of human immunity.

OUR VISION

To be the leading company delivering innovative, 

accessible cell therapies for cancer patients

‌      

OUR MISSION

We strive to discover, develop and deliver novel 

off-the-shelf NK cell therapy product candidates 
that have a profound impact on cancer patients

SCIENCE

온코인사이트_리플렛2_-_복사본_(2)(0003).jpg
다시일번2(0001).png

​​​​


삼번5.png
​​​​
다시오번삼2.jpg
다시오번3.jpg
white.png
칠번1(0001).png

칠번1_-_복사본.png

팔번1.png
구번2(0001).png
구번2-1.png
white.png

PIPELINE

파이프라인.png
파이프라인1.png
white.png

OPEN INNOVATION

openinnovation1.png
2_온코인사이트_리플렛.jpg
white.png
ARTICLE

CONTACT US

+82-2-2088-3455
‌oncoinsight_biz@oncoinsight.co.kr


5th and 6th Floors, R&D Block, Omnibus Park,

222 Banpo-daero, Seocho-gu, Seoul

06591, South Korea